-
PREVALENCE AND RISK FACTORS OF SARCOPENIA IN PATIENTS WITH LUNG CANCER: A SYSTEMATIC REVIEW AND META-ANALYSIS
Aug 11, 2026, 17:16 PM -
ECONOMIC BURDEN OF ONE-YEAR MANAGEMENT OF PEDIATRIC COMBINED IMMUNODEFICIENCY: AN ACTIVITY-BASED COSTING ANALYSIS
Aug 11, 2026, 17:16 PM -
EXPANDING HIV PRE-EXPOSURE PROPHYLAXIS COULD REDUCE NEW HIV INFECTIONS BY 69% AND GENERATE LONG-TERM COST SAVINGS IN ITALY
Aug 11, 2026, 17:16 PM -
COST-EFFECTIVENESS OF AXICABTAGENE CILOLEUCEL VERSUS TISAGENLECLEUCEL FOR THIRD-LINE TREATMENT OF RELAPSED OR REFRACTORY LARGE B-CELL LYMPHOMA: ANALYSIS FROM THE PERSPECTIVE OF THE BRAZILIAN SUPPLEMENTARY HEALTHCARE SYSTEM
Aug 11, 2026, 17:16 PM -
ECONOMIC BURDEN OF STROKE ON BRAZIL'S UNIFIED HEALTH SYSTEM: DIRECT HEALTHCARE COSTS AND ESTIMATED PRODUCTIVITY LOSSES, 2017-2023
Aug 11, 2026, 17:16 PM -
UNDERSTANDING MEANINGFUL ASPECTS OF HEALTH AND EVALUATING CONTENT VALIDITY OF EXISTING COAS IN DOK7-CMS
Aug 11, 2026, 17:16 PM -
PRODUCTIVITY COSTS OF EXPANDING THE AGE RANGE FOR BREAST CANCER SCREENING STRATEGIES IN FRANCE
Aug 11, 2026, 17:16 PM -
ASSESSING THE DEMOGRAPHIC DIVERSITY OF PARTICIPANTS ENROLLED IN RARE AND CHRONIC CONDITION-SPECIFIC, APP-BASED STUDIES
Aug 11, 2026, 17:16 PM -
BRIDGING THE IMAGING-OUTCOMES GAP IN PROSTATE CANCER: CONSTRUCTING LONGITUDINAL COHORTS FROM LINKED RADIOLOGY REPORTS AND CLAIMS DATA
Aug 11, 2026, 17:16 PM -
VALIDATION OF THE CORE OBESITY AND DIABETES MODEL AGAINST A CHRONIC KIDNEY DISEASE MODEL AND OBSERVATIONAL EVIDENCE IN CHRONIC KIDNEY DISEASE
Aug 11, 2026, 17:16 PM -
SAME CONCEPT, DIFFERENT COHORT? COMPARING DIAGNOSIS CODE-BASED (CLAIMS) AND PHQ-9-BASED (SPECIALTY EMR) OPERATIONAL DEFINITIONS OF DEPRESSION IN REAL-WORLD DATA
Aug 11, 2026, 17:16 PM -
HEALTH OUTCOMES BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) DIAGNOSIS STATUS AND RISK LEVEL: FINDINGS FROM THE EU NATIONAL HEALTH AND WELLNESS SURVEY
Aug 11, 2026, 17:16 PM -
HEALTHCARE COSTS FOLLOWING SEVERE RESPIRATORY SYNCYTIAL VIRUS INFECTION IN INFANCY - RESULTS FROM A MATCHED COHORT STUDY IN GERMANY
Aug 11, 2026, 17:16 PM -
EVALUATING THE RELIABILITY OF GENERATIVE AI FOR LITERATURE SCREENING: A COMPARATIVE ANALYSIS OF MANUAL, HYBRID, AND FULLY AUTOMATED APPROACHES
Aug 11, 2026, 17:16 PM -
REGULATORY AND HEALTH TECHNOLOGY ASSESSMENT (HTA) ADAPTATIONS FOR HIGH-COST RARE-DISEASE MEDICINES IN LATIN AMERICA (LATAM): A CROSS-COUNTRY POLICY REVIEW
Aug 11, 2026, 17:16 PM -
THE HIDDEN COST OF ACCESS: INTEGRATING HTA, EVIDENCE GENERATION, AND MANAGED ENTRY AGREEMENT REQUIREMENTS INTO COST-BASED PRICING MODELS FOR CELL AND GENE THERAPIES
Aug 11, 2026, 17:16 PM -
FROM CLINICAL DEVELOPMENT TO REIMBURSEMENT: REAL WORLD EVIDENCE IS THE MISSING LINK FOR IN VITRO DIAGNOSTICS - A CONCEPTUAL FRAMEWORK
Aug 11, 2026, 17:16 PM -
VARIABILITY AND LACK OF STANDARDIZATION IN PATIENT GLOBAL IMPRESSION (PGI) SCALES IN ONCOLOGY CLINICAL TRIALS (2020-2025)
Aug 11, 2026, 17:16 PM -
A GATEWAY TO FUTURE INNOVATIONS: REAL OPTION VALUE (ROV) OF FIRST-LINE CDK4/6 INHIBITORS IN HR+/HER2-NEGATIVE METASTATIC BREAST CANCER
Aug 11, 2026, 17:16 PM -
COST-UTILITY ANALYSIS OF CLOSED LOOP STIMULATION PACEMAKERS VERSUS CONVENTIONAL RATE-ADAPTIVE PACING IN THE UNITED KINGDOM
Aug 11, 2026, 17:16 PM
